# Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC

> **NCT07554846** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 759 (estimated)

## Conditions studied

- Resectable Stage II-IIIa NSCLC

## Interventions

- **DRUG:** Peroperative immunotherapy
- **DRUG:** Neoadjuvant immunotherapy
- **DRUG:** Adjuvant immunotherapy

## Key facts

- **NCT ID:** NCT07554846
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2030-05-01
- **Final completion:** 2032-05-01
- **Target enrollment:** 759 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07554846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07554846, "Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07554846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*